deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT03025477

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer (CHIMOVIP)

Randomized Study Assessing Two Strategies of First Line: a Strategy With Intraperitoneal Chemotherapy and a Strategy With Total Intravenous Strategy, in Patients With Epithelial Advanced Ovarian Cancer

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group

Conditions Ovarian Cancer, Epithelial
Interventions CC0 - Carboplatin (IV) - Paclitaxel (IV) CC0 - Cisplatin (IP) - Epirubicin (IV) CC>0 - Carboplatin (IV)- Paclitaxel (IV) CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)
Updated 8 times since 2017 Last updated: Feb 10, 2021 Started: Oct 31, 2016 Primary completion: Oct 31, 2021 Completion: Oct 31, 2032
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Ovarian Cancer, Epithelial, this trial is actively recruiting participants. The trial is conducted by GERCOR - Multidisciplinary Oncology Cooperative Group and has accumulated 8 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshotRecruiting~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  3. Mar 2021 — Jul 2024 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  5. Mar 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  2. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  3. Feb 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GERCOR - Multidisciplinary Oncology Cooperative Group
  • Groupe Hospitalier Diaconesses Croix Saint-Simon
Data source: Groupe Hospitalier Diaconesses Croix Saint-Simon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations